Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Avidan U. Neumann | Researchclopedia

Back to researchers

Avidan U. Neumann

University of Augsburg ORCID

230

Works

22,792

Citations

58

h-index

133

i10-index

Research Topics

Hepatitis C virus research Hepatitis B Virus Studies Liver Disease Diagnosis and Treatment

Affiliations

Human Genome Sciences (United States)2007–2007

Northwestern University1996–1996

Augsburg University2025–2025

Centre National de la Recherche Scientifique1997–1999

National Institutes of Health2010–2010

Top Works

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

David D. Ho,Avidan U. Neumann,et al.

19954,277 citations

HIV Research and Treatment

Dermatology and Skin Diseases

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

Alan S. Perelson,Avidan U. Neumann,et al.

19963,518 citations

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

Avidan U. Neumann,Nancy P. Lam,et al.

19982,106 citations

The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

Yaoxing Huang,William A. Paxton,et al.

19961,365 citations

Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

Urszula Radzikowska,Mei Ding,et al.

2020577 citations

Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection

Steven M. Wolinsky,Bette Korber,et al.

1996570 citations

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

Guy Gorochov,Avidan U. Neumann,et al.

1998426 citations

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

Leondios G. Kostrikis,Yaoxing Huang,et al.

1998395 citations

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial

Emma Guttman‐Yassky,Patrick M. Brunner,et al.

2018330 citations